This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CM-101

ChemomAb Ltd.

Drug Names(s): CM101, CM 101

Description: CM-101 is a humanized monoclonal antibody targeting eotaxin-2 that was developed using Antitope's Composite Human Antibody technology.


CM-101 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug